📰 Trvn News
Page 3 - Trvn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Trvn. Real-time updates on events, politics, business and more.
June 4, 2023
Equities researchers at StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Get Rating) in a research report issued on Friday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Several other research analysts have also issued reports on TRVN. JMP Securities reissued a “market outperform” rating and issued a $2.00 price target […]
May 29, 2023
StockNews.com initiated coverage on shares of Trevena (NASDAQ:TRVN – Get Rating) in a report published on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. A number of other analysts also recently weighed in on TRVN. JMP Securities restated a market outperform rating and issued a $2.00 target price on shares of […]
May 28, 2023
StockNews.com assumed coverage on shares of Trevena (NASDAQ:TRVN – Get Rating) in a research report released on Thursday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Several other equities research analysts have also issued reports on TRVN. JMP Securities reaffirmed a market outperform rating and set a $2.00 price target on shares […]
May 28, 2023
StockNews.com assumed coverage on shares of Trevena (NASDAQ:TRVN – Get Rating) in a research report released on Thursday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Several other equities research analysts have also issued reports on TRVN. JMP Securities reaffirmed a market outperform rating and set a $2.00 price target on shares […]
May 27, 2023
Trevena, Inc. (NASDAQ:TRVN – Get Rating) saw a large growth in short interest in May. As of May 15th, there was short interest totalling 752,700 shares, a growth of 341.2% from the April 30th total of 170,600 shares. Based on an average trading volume of 2,500,000 shares, the short-interest ratio is currently 0.3 days. Approximately […]
May 26, 2023
Trevena, Inc. (NASDAQ:TRVN – Get Rating) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 752,700 shares, an increase of 341.2% from the April 30th total of 170,600 shares. Currently, 7.1% of the shares of the company are short sold. Based on an […]
May 20, 2023
StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Get Rating) in a research report report published on Wednesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. TRVN has been the subject of a number of other reports. JMP Securities reiterated a market outperform rating and set a $2.00 price target […]
May 17, 2023
Trevena (NASDAQ:TRVN – Get Rating) released its earnings results on Monday. The biopharmaceutical company reported ($0.81) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.85) by $0.04, MarketWatch Earnings reports. The firm had revenue of $0.01 million during the quarter, compared to the consensus estimate of $0.60 million. During the same quarter […]
May 13, 2023
StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Get Rating) in a research note published on Tuesday. The firm issued a sell rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently commented on TRVN. HC Wainwright reduced their price target on Trevena from $11.00 to $9.00 and set […]
May 12, 2023
StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Get Rating) in a research report sent to investors on Tuesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Other research analysts have also recently issued research reports about the company. JMP Securities reaffirmed a market outperform rating and set a $2.00 price […]